Drug lookup
Drug reference

Chlordiazepoxide

Long-acting benzodiazepine · Anxiolytic

Also known as Chlordiazepoxide hydrochloride, Librium

START
Alcohol withdrawal: 50 mg PO q4–6h, taper. Anxiety: 5–10 mg PO TID-QID
TYPICAL MAX
300 mg/day (alcohol withdrawal day 1)
STOP IF
Respiratory depression, severe ataxia/falls, or dependence
WATCH
Sedation, cognition (elderly), falls, respiratory status, taper plan
CDSCO approvedATC N05BA02
Dose laddermg/d
25anxiety low100withdraw start300max d1
Renal dose adjustmenteGFR mL/min/1.73m²
CAUTIONNo fixed adjustment; caution90

KDIGO 2024 + manufacturer label

Pharmacokineticsplasma · t hours
45minONSET2hPEAK3.1d12hDURATION
ONSET
45min · absorption
PEAK
2h · Tmax
3.1d · metabolite t½
DURATION
12h · per dose
EXCRETION
Renal — conjugates
route + CYP
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
Avoid (cleft palate signal 1st trimester; floppy infant near term).
FDA category + note
Top interactionssee all 12
  • MethylnaltrexoneSevereTextbookG&G 14e
  • NalmefeneSevereTextbookG&G 14e
  • NaloxoneSevereTextbookG&G 14e
  • NaltrexoneSevereTextbookG&G 14e

Mechanism

Allosteric agonist at the GABA-A receptor benzodiazepine site, enhancing chloride conductance and producing anxiolysis, sedation, anticonvulsant and muscle-relaxant effects; long active metabolites (desmethylchlordiazepoxide, demoxepam, nordazepam).

Indications

Acute alcohol withdrawalAnxiety (short-term)Pre-operative sedation

Dosing

Adult
Alcohol withdrawal: 50–100 mg PO every 4–6 h on day 1, taper over 5–7 days. Anxiety: 5–25 mg PO 3–4 times daily; short-term.
Pediatric
Avoid <6 y; specialist use otherwise.
Renal adjustment
No fixed adjustment; caution.
Hepatic adjustment
Reduce dose; prolonged action (active metabolites).
Geriatric
Avoid (Beers criteria); if used, lower doses + shorter-acting agents preferred.
Max dose
300 mg/day (alcohol withdrawal day 1, then taper)

Pharmacokinetics

Onset
30–60 min (oral)
Peak effect
~1–4 h (parent); active metabolites peak later
Duration
~12 h (per dose; effective t½ days due to metabolites)
Half-life
Parent 5–30 h; active metabolites ~50–100 h
Bioavailability
Well absorbed orally
Protein binding
~95%
Metabolism
Hepatic CYP3A4 (active metabolites)
Excretion
Renal (conjugates)

Contraindications

  • Severe respiratory insufficiency / sleep apnoea
  • Acute angle-closure glaucoma
  • Myasthenia gravis
  • Severe hepatic impairment
  • Pregnancy
  • Hypersensitivity

Side effects

Common
DrowsinessAtaxiaConfusion (elderly)HeadacheLethargy
Serious
  • Dependence / withdrawal
  • Falls / fractures (elderly)
  • Respiratory depression with opioids/alcohol
  • Paradoxical agitation

Pregnancy & lactation

Pregnancy

Avoid (cleft palate signal 1st trimester; floppy infant near term).

Lactation

Avoid breastfeeding (excretion + neonatal sedation).

Drug interactions

Methylnaltrexone
Severe
Textbook

Increased rates of accidental overdose and death.

Caution is advised, especially for patients with a history of drug abuse.

Source: G&G 14e

Nalmefene
Severe
Textbook

Increased rates of accidental overdose and death.

Caution is advised, especially for patients with a history of drug abuse.

Source: G&G 14e

Naloxone
Severe
Textbook

Increased rates of accidental overdose and death.

Caution is advised, especially for patients with a history of drug abuse.

Source: G&G 14e

Naltrexone
Severe
Textbook

Increased rates of accidental overdose and death.

Caution is advised, especially for patients with a history of drug abuse.

Source: G&G 14e

Other Cns Depressants
Severe
Textbook

Typically fatal if combined in overdose.

Use with extreme caution; avoid if possible.

Source: G&G 14e

Alcohol
Severe
Database

Additive CNS depression

Avoid alcohol while taking

Source: Kimi deep-research + Cla

Alfentanil
Severe
Database

Increased rates of accidental overdose and death.

Caution is advised, especially for patients with a history of drug abuse.

Source: DDInter

Benzhydrocodone
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Buprenorphine
Severe
Database

Increased rates of accidental overdose and death.

Caution is advised, especially for patients with a history of drug abuse.

Source: DDInter

Butorphanol
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Clozapine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Codeine
Severe
Database

Increased rates of accidental overdose and death.

Caution is advised, especially for patients with a history of drug abuse.

Source: DDInter

Related guidelines

Ask House about Chlordiazepoxide

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung·Verified: 2026-05-20 · House clinical team·Cockpit curated: 2026-05-20